Activated Human Cord Blood Platelet-Depleted Plasma (aPDP) is obtained from plasma isolated from healthy donor umbilical cord blood collected with citrate phosphate dextrose adenine (CPDA-1) as anticoagulant. Cord blood units are obtained with the consent of the parents for use in research and treatment. Following removal of platelet from plasma, the PDP is activated using a proprietary process to neutralize the CPD anticoagulant in the cord blood.
aPDP contains high concentration of growth factors and exosomes to supplement to cell cultures. aPDP is processed and cryopreserved within 48 hours after collection of cord blood to achieve maximum quality and viability.